HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor.

Abstract
The hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome is an autosomal dominant disorder caused by mutations of the dual zinc finger transcription factor, GATA3. We investigated 21 HDR probands and 14 patients with isolated hypoparathyroidism for GATA3 abnormalities. Thirteen different heterozygous germline mutations were identified in patients with HDR. These consisted of three nonsense mutations, six frameshifting deletions, two frameshifting insertions, one missense (Leu348Arg) mutation and one acceptor splice site mutation. The splice site mutation was demonstrated to cause a pre-mRNA processing abnormality leading to the use of an alternative acceptor site 8 bp downstream of the normal site, resulting in a frameshift and prematurely terminated protein. Electrophoretic mobility shift assays (EMSAs) revealed three classes of GATA3 mutations: those that lead to a loss of DNA binding which represent over 90% of all mutations, and involved a loss of the carboxy-terminal zinc finger; those that resulted in a reduced DNA-binding affinity; and those (e.g. Leu348Arg) that did not alter DNA binding or the affinity but likely altered the conformational change that occurs during binding in the DNA major groove as predicted by a three-dimensional modeling. These results elucidate further the molecular mechanisms underlying the altered functions of mutants of this zinc finger transcription factor and their role in causing this developmental anomaly. No mutations were identified in patients with isolated hypoparathyroidism, thereby indicating that GATA3 abnormalities are more likely to result in two or more of the phenotypic features of the HDR syndrome and not in one, such as isolated hypoparathyroidism.
AuthorsAsif Ali, Paul T Christie, Irina V Grigorieva, Brian Harding, Hilde Van Esch, S Faisal Ahmed, Maria Bitner-Glindzicz, Eberhard Blind, Catherine Bloch, Patricia Christin, Peter Clayton, Jozef Gecz, Brigitte Gilbert-Dussardier, Encarna Guillen-Navarro, Anna Hackett, Isil Halac, Geoffrey N Hendy, Fiona Lalloo, Christoph J Mache, Zulf Mughal, Albert C M Ong, Choni Rinat, Nicholas Shaw, Sarah F Smithson, John Tolmie, Jacques Weill, M Andrew Nesbit, Rajesh V Thakker
JournalHuman molecular genetics (Hum Mol Genet) Vol. 16 Issue 3 Pg. 265-75 (Feb 01 2007) ISSN: 0964-6906 [Print] England
PMID17210674 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA-Binding Proteins
  • GATA3 Transcription Factor
  • GATA3 protein, human
  • RNA Splice Sites
Topics
  • Abnormalities, Multiple (genetics)
  • Adolescent
  • Adult
  • Amino Acid Sequence
  • Base Sequence
  • Child
  • Child, Preschool
  • DNA-Binding Proteins (genetics, metabolism)
  • Deafness (genetics)
  • Female
  • GATA3 Transcription Factor (genetics, metabolism)
  • Humans
  • Hypoparathyroidism (genetics)
  • Infant
  • Infant, Newborn
  • Kidney (abnormalities)
  • Male
  • Models, Biological
  • Models, Molecular
  • Molecular Sequence Data
  • Mutation
  • Pedigree
  • RNA Splice Sites (genetics)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: